Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,158 | 18,245 | -57,466 | -67,138 | -31,292 |
| Depreciation Amortization | 36,552 | 9,312 | 6,839 | 9,175 | 3,407 |
| Income taxes - deferred | -6,228 | 1,401 | -223 | -1,877 | -8,736 |
| Accounts receivable | 6,876 | -12,643 | -14,930 | -6,218 | -4,631 |
| Accounts payable and accrued liabilities | 3,078 | -4,372 | 5,707 | 582 | -182 |
| Other Working Capital | 13,601 | -14,125 | -6,630 | -7 | -4,102 |
| Other Operating Activity | 34,626 | 67,048 | 61,077 | 23,828 | 26,553 |
| Operating Cash Flow | $64,347 | $64,866 | $-5,626 | $-41,655 | $-18,983 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 486 | -21,829 | -2,575 | -134,689 | N/A |
| PPE Investments | -35,976 | -28,308 | -13,608 | -5,437 | -3,473 |
| Net Acquisitions | -18,727 | N/A | N/A | -26,419 | -63,184 |
| Purchase Of Investment | -5,569 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,533 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,114 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-60,367 | $-50,137 | $-16,183 | $-166,545 | $-66,657 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -115 | -97 | -142 | -122 | -8 |
| Common Stock Issued | 4,622 | 4,998 | 2,978 | 3,325 | 6,546 |
| Other Financing Activity | -11,467 | -8,762 | -5,134 | -1,688 | -1,117 |
| Financing Cash Flow | $-6,960 | $6,139 | $-2,298 | $1,515 | $5,421 |
| Beginning Cash Position | 119,709 | 98,841 | 122,948 | 329,633 | 409,852 |
| End Cash Position | 116,729 | 119,709 | 98,841 | 122,948 | 329,633 |
| Net Cash Flow | $-2,980 | $20,868 | $-24,107 | $-206,685 | $-80,219 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,347 | 64,866 | -5,626 | -41,655 | -18,983 |
| Capital Expenditure | -36,021 | -28,326 | -13,621 | -5,632 | -3,483 |
| Free Cash Flow | 28,326 | 36,540 | -19,247 | -47,287 | -22,466 |